| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 686551 | Null | 0.0392716453377535 | 0.0081190802 |
| NSC 688228 | Null | 0.0392716453377535 | -0.24178531 |
| NSC 693248 | Null | 0.0392716453377535 | -0.037684696 |
| NSC 709974 | Null | 0.0392716453377535 | -0.027006958 |
| NSC 718564 | Null | 0.0392716453377535 | -0.097495856 |
| NSC 725098 | Null | 0.0392716453377535 | -0.17902296 |
| NSC 726089 | 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate | 0.0392716453377535 | -0.24938411 |
| NSC 726217 | Combretastatin A4-analogue | 0.0392716453377535 | -0.023427343 |
| NSC 729166 | N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide | 0.0392716453377535 | -0.078394277 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.0392716453377535 | 0.0095190509 |